Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Complete atrioventricular block during galantamine therapy].

A F G Leentjens1, J A Kragten

  • 1Academisch Ziekenhuis Maastricht, afd. Psychiatrie, Postbus 5800, 6202 AZ Maastricht. a.leentjens@np.unimaas.nl

Nederlands Tijdschrift Voor Geneeskunde
|March 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Consensus Statement on deep brain stimulation for treatment-resistant obsessive-compulsive disorder].

Tijdschrift voor psychiatrie·2024
Same author

Risk factors for behavioral and psychotic dysregulation at the epilepsy monitoring unit in patients with intracranial electrodes.

Epilepsy & behavior : E&B·2023
Same author

Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases.

Journal of atrial fibrillation·2021
Same author

[Ethical issues for the further development of psychiatric deep brain stimulation].

Tijdschrift voor psychiatrie·2021
Same author

The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson's disease.

BMC neurology·2020
Same author

Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivity.

Journal of psychosomatic research·2018

Galantamine, used for Alzheimer's disease, can cause heart problems like bradycardia and heart block. Patients on cholinesterase inhibitors require cardiac screening, including ECG, to prevent adverse effects.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Alzheimer's disease is a progressive neurodegenerative disorder.
  • Cholinesterase inhibitors, such as galantamine, are a common treatment for Alzheimer's.
  • Cardiac side effects of cholinesterase inhibitors are a potential concern.

Observation:

  • A 77-year-old male patient on galantamine for Alzheimer's developed sudden bradycardia and complete atrioventricular block.
  • The patient's cardiac condition necessitated pacemaker implantation.
  • Galantamine treatment was continued post-pacemaker implantation.

Findings:

  • Following pacemaker implantation and continued galantamine treatment, the patient experienced resolution of cardiac symptoms.
  • The patient demonstrated cognitive improvement on a standardized scale.

Related Experiment Videos

  • This case highlights a potential link between galantamine and severe cardiac events.

    • Implications:

    • Cholinesterase inhibitors may pose risks for cardiac arrhythmias.
    • Pre-treatment cardiac screening, including ECG and potassium levels, is crucial for patients initiating cholinesterase inhibitor therapy.
    • Further research is warranted to elucidate the mechanisms and prevalence of cardiac adverse events associated with cholinesterase inhibitors.